Pfizer Hits Acquisition Trifecta: Snaps Up Serenex Hsp90 Candidate, Compound Library And Discovery Platform
This article was originally published in The Pink Sheet Daily
Executive Summary
Separately, Pfizer announces appointment of pharma exec Ringo to senior VP-strategy and business development.
You may also be interested in...
Kosan Buy Puts BMS Front And Center In HSP90 Race, Strengthens Epothilone Position
BMS gains several clinical-stage oncology programs with agreement to acquire Kosan for $190 million.
Kosan Buy Puts BMS Front And Center In HSP90 Race, Strengthens Epothilone Position
BMS gains several clinical-stage oncology programs with agreement to acquire Kosan for $190 million.
Synta’s Melanoma Phase III Could Pack More Punch
Statistical power may reach 99 percent, company says.